Serum levels of adiponectin, an anti-atherosclerotic adipocytokine, increase in patients with decreased renal function and are negatively correlated with the current values of haemoglobin (Hb), in addition to being an independent risk factor for the subsequent development of anaemia [6,7]. This evidence concerns the gene ADIPOQ and anemia (phenotype).